Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model.

Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins DJ.

Am J Hematol. 2011 Feb;86(2):155-62. doi: 10.1002/ajh.21933.

3.

Suppression of a novel hematopoietic mediator in children with severe malarial anemia.

Keller CC, Ouma C, Ouma Y, Awandare GA, Davenport GC, Were T, Hittner JB, Vulule JM, Ong'echa JM, Perkins DJ.

Infect Immun. 2009 Sep;77(9):3864-71. doi: 10.1128/IAI.00342-09. Epub 2009 Jun 15.

4.

Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.

Lamikanra AA, Theron M, Kooij TW, Roberts DJ.

PLoS One. 2009 Dec 24;4(12):e8446. doi: 10.1371/journal.pone.0008446.

5.

Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia.

Keller CC, Davenport GC, Dickman KR, Hittner JB, Kaplan SS, Weinberg JB, Kremsner PG, Perkins DJ.

J Infect Dis. 2006 May 15;193(10):1384-93. Epub 2006 Apr 7.

PMID:
16619186
6.

Severe malarial anemia: innate immunity and pathogenesis.

Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong'echa JM.

Int J Biol Sci. 2011;7(9):1427-42. Epub 2011 Nov 2. Review.

7.

Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal.

Skorokhod OA, Caione L, Marrocco T, Migliardi G, Barrera V, Arese P, Piacibello W, Schwarzer E.

Blood. 2010 Nov 18;116(20):4328-37. doi: 10.1182/blood-2010-03-272781. Epub 2010 Aug 4.

8.

Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.

Xiao W, Koizumi K, Nishio M, Endo T, Osawa M, Fujimoto K, Sato I, Sakai T, Koike T, Sawada Ki.

Exp Hematol. 2002 Nov;30(11):1238-47.

PMID:
12423676
9.

Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Awandare GA, Ouma Y, Ouma C, Were T, Otieno R, Keller CC, Davenport GC, Hittner JB, Vulule J, Ferrell R, Ong'echa JM, Perkins DJ.

Infect Immun. 2007 Jan;75(1):201-10. Epub 2006 Oct 23.

10.

Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Anyona SB, Kempaiah P, Raballah E, Davenport GC, Were T, Konah SN, Vulule JM, Hittner JB, Gichuki CW, Ong'echa JM, Perkins DJ.

Am J Hematol. 2012 Aug;87(8):782-9. doi: 10.1002/ajh.23253. Epub 2012 Jun 23.

11.

Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo.

Casals-Pascual C, Kai O, Cheung JO, Williams S, Lowe B, Nyanoti M, Williams TN, Maitland K, Molyneux M, Newton CR, Peshu N, Watt SM, Roberts DJ.

Blood. 2006 Oct 15;108(8):2569-77. Epub 2006 Jun 27.

12.

Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment.

Lamikanra AA, Merryweather-Clarke AT, Tipping AJ, Roberts DJ.

PLoS One. 2015 Mar 17;10(3):e0119836. doi: 10.1371/journal.pone.0119836. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127124.

13.

A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

McDevitt MA, Xie J, Ganapathy-Kanniappan S, Griffith J, Liu A, McDonald C, Thuma P, Gordeuk VR, Metz CN, Mitchell R, Keefer J, David J, Leng L, Bucala R.

J Exp Med. 2006 May 15;203(5):1185-96. Epub 2006 Apr 24. Erratum in: J Exp Med. 2015 May 4;212(5):825. Shanmugasundaram, Ganapathy [Corrected to Ganapathy-Kanniappan, Shanmugasundaram].

14.

Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.

Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB.

Exp Hematol. 2002 Sep;30(9):990-1000.

PMID:
12225790
15.

TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis.

Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES, Guidotti L, Vitale M, Zauli G.

Blood. 2000 Jun 15;95(12):3716-24.

16.

Tumor necrosis factor alpha and the anemia associated with murine malaria.

Miller KL, Silverman PH, Kullgren B, Mahlmann LJ.

Infect Immun. 1989 May;57(5):1542-6.

17.

Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Martiney JA, Sherry B, Metz CN, Espinoza M, Ferrer AS, Calandra T, Broxmeyer HE, Bucala R.

Infect Immun. 2000 Apr;68(4):2259-67.

19.

Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes.

Campioni D, Secchiero P, Corallini F, Melloni E, Capitani S, Lanza F, Zauli G.

Am J Pathol. 2005 Feb;166(2):557-63.

20.

Plasmodium products contribute to severe malarial anemia by inhibiting erythropoietin-induced proliferation of erythroid precursors.

Thawani N, Tam M, Bellemare MJ, Bohle DS, Olivier M, de Souza JB, Stevenson MM.

J Infect Dis. 2014 Jan 1;209(1):140-9. doi: 10.1093/infdis/jit417. Epub 2013 Aug 6.

PMID:
23922378

Supplemental Content

Support Center